Please login to the form below

Not currently logged in
Email:
Password:

NHS Life Sciences Innovation Delivery Board

The NHS has announced a new Life Sciences Innovation Delivery Board (LSIDB) to develop innovation in drugs and medical technologies in the UK

The NHS has announced the formation of a new Life Sciences Innovation Delivery Board (LSIDB) to develop innovation in drugs and medical technologies in the UK.

The announcement comes days after the decision to create the Centre for Workforce Intelligence which aims to offer guidance and control on the quality of workforce planning across the health service, as the NHS seeks to realise between £15bn and £20bn in efficiency savings.

According to a statement, the LSIDB, will aim to "increase the use of cost effective medicines and medical technologies, improve relationships between the life sciences sector and the NHS and increase the attractiveness of the UK as a site for clinical trials and product development."

The LSIDB will be made up of senior NHS leaders, regulators – including the National Institute for health and Clinical Excellence (NICE), senior policy makers and industry leaders from the field of life sciences.

The UK life sciences industry, which includes pharmaceuticals, medical technology and diagnostics, employs over 120,000 people and invests around £5bn in R&D in the UK. It is hoped the creation of the board will develop an effective partnership with the NHS, increasing quality and efficiency of service both from and between the two bodies.

Mike Farrar, chief executive of NHS North West and chairman of the LSIDB, says: "This is an exciting and important initiative for the NHS. It's hard to think of a more significant, mutually reliant relationship that is conducted under such difficult circumstances. The aim of this new Board is to enable the life sciences industry and the NHS to work together in collaboration for the benefit of patients. This can only be good news for all parties concerned."

1st April 2010

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics